https://www.synconaltd.com/portfolio/late-stage-clinical-companies/
Late-stage clinical companies | Portfolio | Syncona
Syncona has a world-leading cell therapy franchise developing products with the potential to treat patients across a range of diseases.
late stage clinicalcompanies
https://www.synconaltd.com/portfolio/pre-clinical-companies/
Pre-clinical companies | Portfolio | Syncona
Syncona targets innovative technologies in biologics and our company Anaveon is a strong example of this.
clinical companies portfolio
https://www.synconaltd.com/portfolio/commercial-companies/
Commercial companies | Portfolio | Syncona
Syncona has a world-leading cell therapy franchise developing products with the potential to treat patients across a range of diseases.
companies portfolio syncona
https://www.synconaltd.com/portfolio/clinical-companies/
Clinical companies | Portfolio | Syncona
Syncona has one of the largest and highest quality gene therapy platforms globally with the potential to deliver dramatic efficacy across genetic diseases.
clinical companies portfolio
https://www.synconaltd.com/portfolio/commercial-companies/autolus-therapeutics/
Autolus Therapeutics | Commercial companies | Portfolio | Syncona
Autolus is a clinical-stage biopharmaceutical company focusing on the development of precisely targeted, controlled and highly active T effector cell therapies.
companies portfolio syncona
https://www.synconaltd.com/portfolio/clinical-companies/ionctura/
iOnctura | Clinical companies | Portfolio | Syncona
iOnctura is a clinical-stage oncology company developing innovative therapies for neglected and hard-to-treat cancers.
clinical companies portfolio